These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Structure-based design and synthesis of antiparasitic pyrrolopyrimidines targeting pteridine reductase 1. Khalaf AI; Huggan JK; Suckling CJ; Gibson CL; Stewart K; Giordani F; Barrett MP; Wong PE; Barrack KL; Hunter WN J Med Chem; 2014 Aug; 57(15):6479-94. PubMed ID: 25007262 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the Shamshad H; Hafiz A; Althagafi II; Saeed M; Mirza AZ Curr Comput Aided Drug Des; 2020; 16(5):583-598. PubMed ID: 31453790 [TBL] [Abstract][Full Text] [Related]
7. Sesquiterpene Lactones with Dual Inhibitory Activity against the Possart K; Herrmann FC; Jose J; Costi MP; Schmidt TJ Molecules; 2021 Dec; 27(1):. PubMed ID: 35011381 [TBL] [Abstract][Full Text] [Related]
8. Chroman-4-One Derivatives Targeting Pteridine Reductase 1 and Showing Anti-Parasitic Activity. Di Pisa F; Landi G; Dello Iacono L; Pozzi C; Borsari C; Ferrari S; Santucci M; Santarem N; Cordeiro-da-Silva A; Moraes CB; Alcantara LM; Fontana V; Freitas-Junior LH; Gul S; Kuzikov M; Behrens B; Pöhner I; Wade RC; Costi MP; Mangani S Molecules; 2017 Mar; 22(3):. PubMed ID: 28282886 [TBL] [Abstract][Full Text] [Related]
9. Could chroman-4-one derivative be a better inhibitor of PTR1? - Reason for the identified disparity in its inhibitory potency in Trypanosoma brucei and Leishmania major. Omolabi KF; Iwuchukwu EA; Odeniran PO; Soliman MES Comput Biol Chem; 2021 Feb; 90():107412. PubMed ID: 33199197 [TBL] [Abstract][Full Text] [Related]
10. High-resolution structures of Trypanosoma brucei pteridine reductase ligand complexes inform on the placement of new molecular entities in the active site of a potential drug target. Dawson A; Tulloch LB; Barrack KL; Hunter WN Acta Crystallogr D Biol Crystallogr; 2010 Dec; 66(Pt 12):1334-40. PubMed ID: 21123874 [TBL] [Abstract][Full Text] [Related]
11. Multitarget, Selective Compound Design Yields Potent Inhibitors of a Kinetoplastid Pteridine Reductase 1. Pöhner I; Quotadamo A; Panecka-Hofman J; Luciani R; Santucci M; Linciano P; Landi G; Di Pisa F; Dello Iacono L; Pozzi C; Mangani S; Gul S; Witt G; Ellinger B; Kuzikov M; Santarem N; Cordeiro-da-Silva A; Costi MP; Venturelli A; Wade RC J Med Chem; 2022 Jul; 65(13):9011-9033. PubMed ID: 35675511 [TBL] [Abstract][Full Text] [Related]
12. Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferase. Bosch J; Robien MA; Mehlin C; Boni E; Riechers A; Buckner FS; Van Voorhis WC; Myler PJ; Worthey EA; DeTitta G; Luft JR; Lauricella A; Gulde S; Anderson LA; Kalyuzhniy O; Neely HM; Ross J; Earnest TN; Soltis M; Schoenfeld L; Zucker F; Merritt EA; Fan E; Verlinde CL; Hol WG J Med Chem; 2006 Oct; 49(20):5939-46. PubMed ID: 17004709 [TBL] [Abstract][Full Text] [Related]
13. Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases. Tulloch LB; Martini VP; Iulek J; Huggan JK; Lee JH; Gibson CL; Smith TK; Suckling CJ; Hunter WN J Med Chem; 2010 Jan; 53(1):221-9. PubMed ID: 19916554 [TBL] [Abstract][Full Text] [Related]